MAM
ABMD

Monaco Asset Management’s Abiomed Inc ABMD Stock Holding History

Monaco Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,500
Closed -$1.28M – 89
2019
Q4 		$1.28M Buy
+7,500
New +$1.39M 0.57% 38

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Monaco Asset Management's ABMD Position: Q1 2020 in Review

Monaco Asset Management sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 7,500 shares — an estimated $1.28M sold.

Monaco Asset Management first reported a position in ABMD in Q4 2019 and held it in 1 quarter. The position peaked at $1.28M in Q4 2019. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Monaco Asset Management reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Monaco Asset Management sold 7,500 Abiomed Inc shares in Q1 2020, an estimated $1.28M.
  • Monaco Asset Management first reported a position in Abiomed Inc in Q4 2019 and held it in 1 quarter.
  • Monaco Asset Management's Abiomed Inc position peaked at $1.28M in Q4 2019.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Monaco Asset Management's 13F filing for Q1 2020, filed 12 May 2020.